Hostname: page-component-76d6cb85b7-lrvh5 Total loading time: 0 Render date: 2026-07-15T22:57:04.256Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin-Resistant Enterococcus (VRE) Transmission and Risk Factors in Contacts of VRE Carriers

Published online by Cambridge University Press:  10 May 2016

Reham Kaki ,
Yang Yu ,
Cindy O’Neill ,
Christine Lee ,
Dominik Mertz  and
Hamilton Health Sciences Infection Prevention and Control Team
Reham Kaki
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Yang Yu
Affiliation:
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Cindy O’Neill
Affiliation:
Hamilton Health Sciences, Hamilton, Ontario, Canada
Christine Lee
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences, Hamilton, Ontario, Canada St. Joseph’s Healthcare, Hamilton, Ontario, Canada
Dominik Mertz*
Affiliation:
Department of Medicine, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences, Hamilton, Ontario, Canada Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; and Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, Ontario, Canada
*
Juravinski Hospital and Cancer Center, 711 Concession Street, Section M, Level 1, Room 3, Hamilton, Ontario L8V 1C3, Canada (mertzd@mcmaster.ca).
Get access Rights & Permissions [Opens in a new window]

Extract

During a 2-year period, the vancomycin-resistant enterococcus (VRE) acquisition rate was 10.9% (40/368) in patients who had shared a room with a newly detected VRE carrier. Exposure to vancomycin and to anti-anaerobic antibiotics were identified as independent risk factors for VRE acquisition. Sensitivity of the first rectal VRE screening was less than 50%.

Infect Control Hosp Epidemiol 2014;35(7):876–879

Information

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 7 , July 2014 , pp. 876 - 879
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. DiazGranados, CA, Zimmer, SM, Klein, M, Jernigan, JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41(3):327–333.CrossRefGoogle ScholarPubMed
2. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10 suppl 2):S165–S193.Google Scholar
3. Tacconelli, E, Cataldo, MA. Vancomycin-resistant enterococci (VRE): transmission and control. Int J Antimicrob Agents 2008;31(2):99–106.Google Scholar
4. Tacconelli, E, Karchmer, AW, Yokoe, D, D’Agata, EM. Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. Clin Infect Dis 2004;39(7):964–970.CrossRefGoogle ScholarPubMed
5. Carmeli, Y, Eliopoulos, GM, Samore, MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002;8(8):802–807.CrossRefGoogle ScholarPubMed
6. Bonten, MJ, Slaughter, S, Ambergen, AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158(10):1127–1132.Google Scholar
7. Drees, M, Snydman, DR, Schmid, CH, et al. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2008;29(8):709–715.Google Scholar
8. Zhou, Q, Moore, C, Eden, S, Tong, A, McGeer, A. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital. Infect Control Hosp Epidemiol 2008;29(5):398–403.CrossRefGoogle ScholarPubMed
9. Bass, P, Karki, S, Rhodes, D, et al. Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology-oncology patients. Am J Infect Control 2013;41(4):345–348.Google Scholar
10. Moore, C, Dhaliwal, J, Tong, A, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition in roommate contacts of patients colonized or infected with MRSA in an acute-care hospital. Infect Control Hosp Epidemiol 2008;29(7):600–606.Google Scholar